Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 May;70(5):2950–2956. doi: 10.1128/jvi.70.5.2950-2956.1996

Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies.

D E Goade 1, R Bell 1, T Yamada 1, G J Mertz 1, S Jenison 1
PMCID: PMC190153  PMID: 8627770

Abstract

Herpes simplex virus type 2 (HSV-2) glycoprotein B (gB-2) gene segments were expressed as recombinant proteins in Escherichia coli. gB-2 recombinant proteins were reacted with human serum immunoglobulin G (IgG) antibodies in Western immunoblot assays. Initially, samples were tested for the presence of HSV-1-specific antibodies and HSV-2-specific antibodies by using HSV-infected cell lysates as antigen targets in Western blot assays. Serum samples that contained HSV-2-specific IgG (n = 58), HSV-1-specific IgG (n = 33), or no detectable HSV antibodies (n = 31) were tested for reactivities with the gB-2 recombinant proteins. In 58 of 58 samples that contained HSV-2-specific IgG, antibodies were present that reacted strongly with a gB-2 amino-proximal segment between amino acids (aa) 18 and 75. Three of 33 serum samples that contained HSV-1- and not HSV-2-specific IgG (as defined by the HSV lysate Western blot assay) reacted with this segment. Both HSV-2 antibodies and HSV-1 antibodies reacted strongly with a carboxy-terminal gB-2 segment between aa 819 and 904; a second minor cross-reactive region was mapped to a gB-2 segment between aa 564 and 626. The gB-2 segment from aa 18 to 75 may constitute a useful reagent for the virus type-specific serodiagnosis of HSV-2 infections. Further studies will be required to determine the relative sensitivities and specificities of the assay for gB-2 aa 18 to 75, HSV gG assays, and HSV lysate Western blot assays for detecting virus type-specific antibody responses in acute and chronic HSV-2 infections.

Full Text

The Full Text of this article is available as a PDF (318.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashley R. L., Corey L. Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virus. J Clin Invest. 1984 Mar;73(3):681–688. doi: 10.1172/JCI111260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashley R. L. Laboratory techniques in the diagnosis of herpes simplex infection. Genitourin Med. 1993 Jun;69(3):174–183. doi: 10.1136/sti.69.3.174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ashley R. L., Militoni J., Lee F., Nahmias A., Corey L. Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol. 1988 Apr;26(4):662–667. doi: 10.1128/jcm.26.4.662-667.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ashley R. L., Militoni J. Use of densitometric analysis for interpreting HSV serologies based on Western blot. J Virol Methods. 1987 Nov;18(2-3):159–168. doi: 10.1016/0166-0934(87)90121-2. [DOI] [PubMed] [Google Scholar]
  5. Ashley R., Benedetti J., Corey L. Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes. J Med Virol. 1985 Oct;17(2):153–166. doi: 10.1002/jmv.1890170208. [DOI] [PubMed] [Google Scholar]
  6. Baghian A., Huang L., Newman S., Jayachandra S., Kousoulas K. G. Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion. J Virol. 1993 Apr;67(4):2396–2401. doi: 10.1128/jvi.67.4.2396-2401.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Becker Y. Computer prediction of antigenic and topogenic domains in HSV-1 and HSV-2 glycoprotein B (gB). Virus Genes. 1992 Apr;6(2):131–141. doi: 10.1007/BF01703062. [DOI] [PubMed] [Google Scholar]
  8. Bernstein D. I., Bryson Y. J., Lovett M. A. Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides. J Med Virol. 1985 Mar;15(3):251–263. doi: 10.1002/jmv.1890150306. [DOI] [PubMed] [Google Scholar]
  9. Bernstein D. I., Frenkel L. M., Bryson Y. J., Myers M. G. Antibody response to herpes simplex virus glycoproteins gB and gD. J Med Virol. 1990 Jan;30(1):45–49. doi: 10.1002/jmv.1890300110. [DOI] [PubMed] [Google Scholar]
  10. Blacklaws B. A., Krishna S., Minson A. C., Nash A. A. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology. 1990 Aug;177(2):727–736. doi: 10.1016/0042-6822(90)90539-4. [DOI] [PubMed] [Google Scholar]
  11. Burke R. L. Contemporary approaches to vaccination against herpes simplex virus. Curr Top Microbiol Immunol. 1992;179:137–158. doi: 10.1007/978-3-642-77247-4_9. [DOI] [PubMed] [Google Scholar]
  12. Burke R. L. Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use. Rev Infect Dis. 1991 Nov-Dec;13 (Suppl 11):S906–S911. doi: 10.1093/clind/13.supplement_11.s906. [DOI] [PubMed] [Google Scholar]
  13. Bzik D. J., Debroy C., Fox B. A., Pederson N. E., Person S. The nucleotide sequence of the gB glycoprotein gene of HSV-2 and comparison with the corresponding gene of HSV-1. Virology. 1986 Dec;155(2):322–333. doi: 10.1016/0042-6822(86)90196-0. [DOI] [PubMed] [Google Scholar]
  14. Bzik D. J., Fox B. A., DeLuca N. A., Person S. Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion. Virology. 1984 Aug;137(1):185–190. doi: 10.1016/0042-6822(84)90022-9. [DOI] [PubMed] [Google Scholar]
  15. Cai W. Z., Person S., DebRoy C., Gu B. H. Functional regions and structural features of the gB glycoprotein of herpes simplex virus type 1. An analysis of linker insertion mutants. J Mol Biol. 1988 Jun 5;201(3):575–588. doi: 10.1016/0022-2836(88)90639-0. [DOI] [PubMed] [Google Scholar]
  16. Cai W. Z., Person S., Warner S. C., Zhou J. H., DeLuca N. A. Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1. J Virol. 1987 Mar;61(3):714–721. doi: 10.1128/jvi.61.3.714-721.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Cantin E. M., Eberle R., Baldick J. L., Moss B., Willey D. E., Notkins A. L., Openshaw H. Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc Natl Acad Sci U S A. 1987 Aug;84(16):5908–5912. doi: 10.1073/pnas.84.16.5908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Chapsal J. M., Pereira L. Characterization of epitopes on native and denatured forms of herpes simplex virus glycoprotein B. Virology. 1988 Jun;164(2):427–434. doi: 10.1016/0042-6822(88)90556-9. [DOI] [PubMed] [Google Scholar]
  19. Corey L. Clinical studies with herpes simplex virus type 2 Curtis strain vaccine. Rev Infect Dis. 1991 Nov-Dec;13 (Suppl 11):S904–S905. doi: 10.1093/clind/13.supplement_11.s904. [DOI] [PubMed] [Google Scholar]
  20. Eberle R., Courtney R. J. Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera. Infect Immun. 1981 Mar;31(3):1062–1070. doi: 10.1128/iai.31.3.1062-1070.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Eberle R., Courtney R. J. Topological distribution of virus-specific and cross-reactive antigenic determinants on the gB glycoprotein of the herpes simplex viruses. J Med Virol. 1989 Apr;27(4):309–316. doi: 10.1002/jmv.1890270410. [DOI] [PubMed] [Google Scholar]
  22. Gage P. J., Levine M., Glorioso J. C. Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. J Virol. 1993 Apr;67(4):2191–2201. doi: 10.1128/jvi.67.4.2191-2201.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gilman S. C., Docherty J. J., Rawls W. E. Antibody responses in humans to individual proteins of herpes simplex viruses. Infect Immun. 1981 Dec;34(3):880–887. doi: 10.1128/iai.34.3.880-887.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Goodman J. L., Engel J. P. Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein B. J Virol. 1991 Apr;65(4):1770–1778. doi: 10.1128/jvi.65.4.1770-1778.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Henikoff S. Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene. 1984 Jun;28(3):351–359. doi: 10.1016/0378-1119(84)90153-7. [DOI] [PubMed] [Google Scholar]
  26. Highlander S. L., Cai W. H., Person S., Levine M., Glorioso J. C. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J Virol. 1988 Jun;62(6):1881–1888. doi: 10.1128/jvi.62.6.1881-1888.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Highlander S. L., Dorney D. J., Gage P. J., Holland T. C., Cai W., Person S., Levine M., Glorioso J. C. Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration. J Virol. 1989 Feb;63(2):730–738. doi: 10.1128/jvi.63.2.730-738.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jenison S. A., Firzlaff J. M., Langenberg A., Galloway D. A. Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coli-expressed fusion proteins. J Virol. 1988 Jun;62(6):2115–2123. doi: 10.1128/jvi.62.6.2115-2123.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jenison S. A., Yu X. P., Valentine J. M., Galloway D. A. Characterization of human antibody-reactive epitopes encoded by human papillomavirus types 16 and 18. J Virol. 1991 Mar;65(3):1208–1218. doi: 10.1128/jvi.65.3.1208-1218.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Jenison S. A., Yu X. P., Valentine J. M., Galloway D. A. Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope. J Virol. 1989 Feb;63(2):809–818. doi: 10.1128/jvi.63.2.809-818.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Jenison S., Yamada T., Morris C., Anderson B., Torrez-Martinez N., Keller N., Hjelle B. Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol. 1994 May;68(5):3000–3006. doi: 10.1128/jvi.68.5.3000-3006.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kahlon J., Lakeman F. D., Ackermann M., Whitley R. J. Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection. J Clin Microbiol. 1986 Apr;23(4):725–730. doi: 10.1128/jcm.23.4.725-730.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Koerner T. J., Hill J. E., Myers A. M., Tzagoloff A. High-expression vectors with multiple cloning sites for construction of trpE fusion genes: pATH vectors. Methods Enzymol. 1991;194:477–490. doi: 10.1016/0076-6879(91)94036-c. [DOI] [PubMed] [Google Scholar]
  34. Kohl S., Strynadka N. C., Hodges R. S., Pereira L. Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B. J Clin Invest. 1990 Jul;86(1):273–278. doi: 10.1172/JCI114695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kousoulas K. G., Huo B., Pereira L. Antibody-resistant mutations in cross-reactive and type-specific epitopes of herpes simplex virus 1 glycoprotein B map in separate domains. Virology. 1988 Oct;166(2):423–431. doi: 10.1016/0042-6822(88)90513-2. [DOI] [PubMed] [Google Scholar]
  36. Kousoulas K. G., Pellett P. E., Pereira L., Roizman B. Mutations affecting conformation or sequence of neutralizing epitopes identified by reactivity of viable plaques segregate from syn and ts domains of HSV-1(F) gB gene. Virology. 1984 Jun;135(2):379–394. doi: 10.1016/0042-6822(84)90194-6. [DOI] [PubMed] [Google Scholar]
  37. Kousoulas K., Arsenakis M., Pereira L. A subset of type-specific epitopes map in the amino terminus of herpes simplex virus type 1 glycoprotein B. J Gen Virol. 1989 Mar;70(Pt 3):735–741. doi: 10.1099/0022-1317-70-3-735. [DOI] [PubMed] [Google Scholar]
  38. Langenberg A. G., Burke R. L., Adair S. F., Sekulovich R., Tigges M., Dekker C. L., Corey L. A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]. Ann Intern Med. 1995 Jun 15;122(12):889–898. doi: 10.7326/0003-4819-122-12-199506150-00001. [DOI] [PubMed] [Google Scholar]
  39. Lee F. K., Coleman R. M., Pereira L., Bailey P. D., Tatsuno M., Nahmias A. J. Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol. 1985 Oct;22(4):641–644. doi: 10.1128/jcm.22.4.641-644.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Lehtinen M., Koivisto V., Lehtinen T., Paavonen J., Leinikki P. Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2. Intervirology. 1985;24(1):18–25. doi: 10.1159/000149614. [DOI] [PubMed] [Google Scholar]
  41. McClung H., Seth P., Rawls W. E. Relative concentrations in human sera of antibodies to cross-reacting and specific antigens of Herpes simplex virus types 1 and 2. Am J Epidemiol. 1976 Aug;104(2):192–201. doi: 10.1093/oxfordjournals.aje.a112289. [DOI] [PubMed] [Google Scholar]
  42. Mertz G. J., Ashley R., Burke R. L., Benedetti J., Critchlow C., Jones C. C., Corey L. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection. J Infect Dis. 1990 Apr;161(4):653–660. doi: 10.1093/infdis/161.4.653. [DOI] [PubMed] [Google Scholar]
  43. Mester J. C., Highlander S. L., Osmand A. P., Glorioso J. C., Rouse B. T. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B. J Virol. 1990 Nov;64(11):5277–5283. doi: 10.1128/jvi.64.11.5277-5283.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Navarro D., Paz P., Pereira L. Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion. Virology. 1992 Jan;186(1):99–112. doi: 10.1016/0042-6822(92)90064-v. [DOI] [PubMed] [Google Scholar]
  45. Parkes D. L., Smith C. M., Rose J. M., Brandis J., Coates S. R. Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G. J Clin Microbiol. 1991 Apr;29(4):778–781. doi: 10.1128/jcm.29.4.778-781.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Pellett P. E., Kousoulas K. G., Pereira L., Roizman B. Anatomy of the herpes simplex virus 1 strain F glycoprotein B gene: primary sequence and predicted protein structure of the wild type and of monoclonal antibody-resistant mutants. J Virol. 1985 Jan;53(1):243–253. doi: 10.1128/jvi.53.1.243-253.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Pereira L., Ali M., Kousoulas K., Huo B., Banks T. Domain structure of herpes simplex virus 1 glycoprotein B: neutralizing epitopes map in regions of continuous and discontinuous residues. Virology. 1989 Sep;172(1):11–24. doi: 10.1016/0042-6822(89)90102-5. [DOI] [PubMed] [Google Scholar]
  48. Qadri I., Gimeno C., Navarro D., Pereira L. Mutations in conformation-dependent domains of herpes simplex virus 1 glycoprotein B affect the antigenic properties, dimerization, and transport of the molecule. Virology. 1991 Jan;180(1):135–152. doi: 10.1016/0042-6822(91)90017-6. [DOI] [PubMed] [Google Scholar]
  49. Sanchez-Pescador L., Paz P., Navarro D., Pereira L., Kohl S. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity. J Infect Dis. 1992 Sep;166(3):623–627. doi: 10.1093/infdis/166.3.623. [DOI] [PubMed] [Google Scholar]
  50. Sanchez-Pescador L., Pereira L., Charlebois E. D., Kohl S. Antibodies to epitopes of herpes simplex virus type 1 glycoprotein B (gB) in human sera: analysis of functional gB epitopes defined by inhibition of murine monoclonal antibodies. J Infect Dis. 1993 Oct;168(4):844–853. doi: 10.1093/infdis/168.4.844. [DOI] [PubMed] [Google Scholar]
  51. Sarmiento M., Haffey M., Spear P. G. Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity. J Virol. 1979 Mar;29(3):1149–1158. doi: 10.1128/jvi.29.3.1149-1158.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Stanberry L. R., Bernstein D. I., Burke R. L., Pachl C., Myers M. G. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J Infect Dis. 1987 May;155(5):914–920. doi: 10.1093/infdis/155.5.914. [DOI] [PubMed] [Google Scholar]
  53. Stuve L. L., Brown-Shimer S., Pachl C., Najarian R., Dina D., Burke R. L. Structure and expression of the herpes simplex virus type 2 glycoprotein gB gene. J Virol. 1987 Feb;61(2):326–335. doi: 10.1128/jvi.61.2.326-335.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Vestergaard B. F. Herpes simplex virus antigens and antibodies: a survey of studies based on quantitative immunoelectrophoresis. Rev Infect Dis. 1980 Nov-Dec;2(6):899–913. doi: 10.1093/clinids/2.6.899. [DOI] [PubMed] [Google Scholar]
  55. Yaegashi N., Jenison S. A., Batra M., Galloway D. A. Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11. J Virol. 1992 Apr;66(4):2008–2019. doi: 10.1128/jvi.66.4.2008-2019.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Yamada T., Hjelle B., Lanzi R., Morris C., Anderson B., Jenison S. Antibody responses to Four Corners hantavirus infections in the deer mouse (Peromyscus maniculatus): identification of an immunodominant region of the viral nucleocapsid protein. J Virol. 1995 Mar;69(3):1939–1943. doi: 10.1128/jvi.69.3.1939-1943.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES